Clinical trial Recruiting at 1 site Observational

Chemokeyp: A Feasibility Check for Quick Safety Data in Cancer Care

Official title: Chemokeyp: A Feasibility Study to Evaluate and Further Develop Patient Safety Software Enabling Efficient and Effective Information Exchange for Patients Undergoing Systemic Cancer Treatment Who Access Emergency or Unscheduled Care.

Run by St Vincent's University Hospital, Ireland · NCT07592234 · Data updated 2026-11-12

This study tests a secure, patient-facing wristband and ED-access portal to help track possible treatment-related safety events in cancer patients receiving chemotherapy.

More Patient Safety trials

Quick facts

Study typeObservational
SexAll
Enrollment100 (estimated)
SponsorSt Vincent's University Hospital, Ireland
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Dublin, Dublin)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedAugust 1, 2026
Study endsJanuary 1, 2027
Registry record updatedMay 18, 2026
Trial IDNCT07592234 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults receiving cancer treatment at St Vincent’s University Hospital who can provide informed consent and participate in safety data reporting.

Probably not a fit

Patients who are unable to consent or who do not require ED care related to chemotherapy may not receive any direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Chemokeyp is an observational feasibility study that uses a secure ED-oncology interface for patients on chemotherapy. When patients visit the Emergency Department, staff can scan a QR code on a medical-alert wristband to access a brief, predefined safety questionnaire about potential adverse events. The portal collects structured safety data for research and signal detection, without interacting with the patient’s electronic health record or altering standard clinical care. Data entry is limited to specific fields and is intended to test the practicality and timeliness of real-time safety reporting in unscheduled care settings. The study is conducted at St Vincent’s University Hospital in Dublin and focuses on safety data capture rather than clinical decision support.

Why it matters

Potential benefit: If successful, the approach could enable faster safety signals and better understanding of chemotherapy-related adverse events in real-world ED encounters.

How similar studies have gone: Previous efforts show that streamlined, patient-facing safety reporting can be feasible, though this exact ED-oncology data-capture approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient undergoing treatment for cancer at SVUH

Exclusion Criteria:

* Presence of a condition(s) or diagnosis, either physical or psychological, or physical exam finding that precludes participation (inability to give informed consent)

Where it's running

  • St Vincent's University Hospital
    Dublin, Dublin, Ireland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.